Home News & Events Events Workshops Workshops Workshop Beginners/Intermediate Online NONMEM/PDx-Pop workshop Date 27 January 2026 - 28 January 2026 Time 09:00 - 16:00 Location Online/Virtual Webex Timezone America/New York Workshop Advanced Online NONMEM/PDx-Pop workshop Date 29 January 2026 Time 09:00 - 16:00 Location Online/Virtual Webex Timezone America/New York In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events Webinars Workshops Webinars Social media Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related Information Webpage Webinars Webpage Industry Events What’s happening in ICON ICON Plc In this new blog series, we review ISO 14971 (Application of risk management to medical devices) - its history, the principles embedded within it and how it relates to other standards and regulation. For the first editio... 17h 1 View post View webpage ICON Plc Meet ICON experts at the AASLD to learn how ICON partners with sponsors, investigators, patients and other collaborators to deliver strategic, data-driven solutions for MASH and hepatology studies. https://ow.ly/9QBn50X8... 18h 2 View post View webpage ICON Plc Digital measures, including digital biomarkers and digital endpoints, offer sponsors powerful ways to assess treatment effect in real time, in the real world. But to be meaningful, those measures must be carefully selec... 20h 5 View post View webpage ICON Plc Teams incorporating DHTs into their protocol design may grapple with the question of how to transform raw sensor data into a validated, regulatory-ready digital endpoint. Start with the V3 framework: 🔬 Verification 📊... 20h View post View webpage ICON Plc The PHUSE single day event in Bloemfontein will bring together leading professionals to explore innovations shaping clinical data science. ICON is proud to contribute to these discussions, focusing on topics such as digi... 21h View post View webpage ICON Plc Post-marketing pharmacovigilance plays a crucial role in maintaining patient safety once a product reaches the market. While automation can streamline certain tasks, its implementation must be carefully managed to avoid ... 22h View post View webpage ICON Plc Early clinical trial designs—especially first-in-human (FIH) studies—are increasingly tailored to the unique needs of specific therapeutic areas. In neurodegenerative diseases, there is a growing shift toward flexible an... 23h 2 View post View webpage ICON Plc ICON is proud to be recognised among the top global companies in the world for female employees. As of 31 December 2024, women make up 70% of our workforce and hold 60% of director-level and above roles—a powerful refle... 4 Nov View post View webpage ICON Plc By prioritising community engagement, enabling remote enrollment, and clearly communicating risks and benefits, researchers and sponsors can help create safer, more inclusive clinical trials for pregnant individuals. Exp... 3 Nov View post View webpage ICON Plc Planning an Integrated Summary of Safety and Efficacy (ISS/ISE) submission can be demanding, especially when studies differ in format or terminology. This blog explains how early preparation and the right integration str... 3 Nov 3 View post View webpage ICON Plc Connect with ICON experts at #ObesityWeek, booth \#520 to learn about our proven success designing and executing early phase studies, supported by a robust database of overweight/obese volunteers and in-house clinical re... 3 Nov View post View webpage ICON Plc Over the past five years, ICON has participated in over 840 oncology and haematologic malignancy, and 83 non-malignant haematology, clinical studies globally. Meet ICON experts at #ASH25, booth \#2161 to learn how our fl... 3 Nov View post View webpage
